Correlation Between Candel Therapeutics and Xenon Pharmaceuticals

Can any of the company-specific risk be diversified away by investing in both Candel Therapeutics and Xenon Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Candel Therapeutics and Xenon Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Candel Therapeutics and Xenon Pharmaceuticals, you can compare the effects of market volatilities on Candel Therapeutics and Xenon Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Candel Therapeutics with a short position of Xenon Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Candel Therapeutics and Xenon Pharmaceuticals.

Diversification Opportunities for Candel Therapeutics and Xenon Pharmaceuticals

-0.05

Correlation Coefficient

Candel Therapeutics  Xenon Pharmaceuticals

Good diversification

The 3 months correlation between Candel and Xenon is -0.05. Overlapping area represents the amount of risk that can be diversified away by holding Candel Therapeutics and Xenon Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Xenon Pharmaceuticals and Candel Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Candel Therapeutics are associated (or correlated) with Xenon Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Xenon Pharmaceuticals has no effect on the direction of Candel Therapeutics i.e., Candel Therapeutics and Xenon Pharmaceuticals go up and down completely randomly.

Pair Corralation between Candel Therapeutics and Xenon Pharmaceuticals

Given the investment horizon of 90 days Candel Therapeutics is expected to under-perform the Xenon Pharmaceuticals. In addition to that, Candel Therapeutics is 3.26 times more volatile than Xenon Pharmaceuticals. It trades about -0.03 of its total potential returns per unit of risk. Xenon Pharmaceuticals is currently generating about -0.09 per unit of volatility. If you would invest  3,883  in Xenon Pharmaceuticals on December 27, 2024 and sell it today you would lose (437.00) from holding Xenon Pharmaceuticals or give up 11.25% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Candel Therapeutics  vs.  Xenon Pharmaceuticals

Candel Therapeutics

Risk-Adjusted Performance

Very Weak

Over the last 90 days Candel Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest unsteady performance, the Stock's fundamental indicators remain persistent and the latest mess on Wall Street may also be a sign of long-standing gains for the company institutional investors.

Xenon Pharmaceuticals

Risk-Adjusted Performance

Very Weak

Over the last 90 days Xenon Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest conflicting performance, the Stock's basic indicators remain sound and the latest tumult on Wall Street may also be a sign of longer-term gains for the firm shareholders.

Pair Trading with Candel Therapeutics and Xenon Pharmaceuticals

The main advantage of trading using opposite Candel Therapeutics and Xenon Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Candel Therapeutics position performs unexpectedly, Xenon Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Xenon Pharmaceuticals will offset losses from the drop in Xenon Pharmaceuticals' long position.

The idea behind Candel Therapeutics and Xenon Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.